John Smeraglia

Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related proteins

Samuel E. DePrimo, Carlo L. Bello, John Smeraglia et al. · Journal of Translational Medicine · 2007 · 320 citations · Full text

EBF Recommendation on the Validation of Bioanalytical Methods for Dried Blood Spots

Philip Timmerman, Steve White, Susanne Globig et al. · Bioanalysis · 2011 · 179 citations

Engineering, Pathology, Dermatology +21

Effect of food on the pharmacokinetics of sunitinib malate (SU11248), a multi-targeted receptor tyrosine kinase inhibitor: results from a phase I study in healthy subjects

Carlo L. Bello, Laurie Sherman, Jihao Zhou et al. · Anti-Cancer Drugs · 2006 · 134 citations

Nutrition, Oral Bioavailability, Healthy Subjects +17

Matrix effects and selectivity issues in LC-MS-MS

John Smeraglia, S. F. Baldrey, David G. Watson · Chromatographia · 2002 · 85 citations

Matrix Effects, Resonance, Matrix Method +2

2015 White Paper on Recent Issues in Bioanalysis: Focus on New Technologies and Biomarkers (Part 3 – Lba, Biomarkers and Immunogenicity)

Lakshmi Amaravadi, An Song, Heather Myler et al. · Bioanalysis · 2015 · 74 citations · Full text